Skip to main content
EyeGene,Inc logo

EyeGene,Inc — Investor Relations & Filings

Ticker · 185490 ISIN · KR7185490000 KO Professional, scientific and technical activities
Open in API
Filings indexed 314 across all filing types
Latest filing 2020-12-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 185490

About EyeGene,Inc

https://eyegene.co.kr/en/

EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (specifically noting the resignation of an executive and the resulting change in special relationship status). This falls under the category of Major Shareholding Notification (MRQ).
2020-12-03 Korean
기타경영사항(특허권취득)(자율공시)
Investor Presentation Classification · 95% confidence The document is a voluntary disclosure ('자율공시') regarding the acquisition of a patent ('특허권 취득') by the company Eutilex (아이진). It details the patent name, content, inventors, and its application in vaccine development. Since this is a regulatory announcement regarding a specific corporate event (patent acquisition) that does not fit into financial reporting, shareholder meetings, or management changes, it falls under the 'Regulatory Filings' category as the appropriate fallback.
2020-11-24 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '아이진(주)' (Eyegene Inc.) covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial information, business overviews, capital changes, and management discussions, which are characteristic of a comprehensive interim financial report. It is not a mere announcement or certification, but the full report itself. 9M 2020
2020-11-16 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the acquisition of convertible bonds before maturity by the issuer (Eutilex/Eyegene). It details the bond type, acquisition amount, acquisition date, and the reason for the acquisition (agreement with bondholders). This falls under capital structure changes and financing activities, specifically related to debt management, which is classified as CAP (Capital/Financing Update).
2020-10-23 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the acquisition of convertible bonds before maturity (early redemption) by the company. It details the bond series, acquisition amount, acquisition date, and the reason for the acquisition (exercise of put option by bondholders). This falls under capital structure changes and financing activities, specifically related to debt management. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate classification for updates on financing activities and capital structure changes.
2020-09-28 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal disclosure titled '증권 발행결과' (Securities Issuance Result) regarding the issuance of private placement bonds with warrants (신주인수권부사채). It details the issuance method, amount, and payment date. This falls under the category of capital and financing updates, specifically related to the company's capital structure and financing activities.
2020-09-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.